135 related articles for article (PubMed ID: 19426672)
1. A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells.
Jeong SH; Jo WS; Song S; Suh H; Seol SY; Leem SH; Kwon TK; Yoo YH
Biochem Pharmacol; 2009 Apr; 77(8):1337-47. PubMed ID: 19426672
[TBL] [Abstract][Full Text] [Related]
2. A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells.
Jeong SH; Lee JS; Jeong NY; Kim TH; Yoo KS; Song S; Suh H; Kwon TK; Park BS; Yoo YH
Int J Oncol; 2009 Dec; 35(6):1353-60. PubMed ID: 19885558
[TBL] [Abstract][Full Text] [Related]
3. B1, a novel amonafide analogue, overcomes the resistance conferred by Bcl-2 in human promyelocytic leukemia HL60 cells.
Liang X; Xu Y; Xu K; Liu J; Qian X
Mol Cancer Res; 2010 Dec; 8(12):1619-32. PubMed ID: 21076048
[TBL] [Abstract][Full Text] [Related]
4. The novel resveratrol analog HS-1793-induced polyploid LNCaP prostate cancer cells are vulnerable to downregulation of Bcl-xL.
Jeong NY; Yoon YG; Rho JH; Lee JS; Lee SY; Yoo KS; Song S; Suh H; Choi YH; Yoo YH
Int J Oncol; 2011 Jun; 38(6):1597-604. PubMed ID: 21424121
[TBL] [Abstract][Full Text] [Related]
5. An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression.
Jeong SH; Song IS; Kim HK; Lee SR; Song S; Suh H; Yoon YG; Yoo YH; Kim N; Rhee BD; Ko KS; Han J
Mol Cells; 2012 Oct; 34(4):357-65. PubMed ID: 23104437
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of resveratrol and novel resveratrol derivative, HS-1793, on endoplasmic reticulum stress-mediated apoptosis and Akt inactivation.
Um HJ; Bae JH; Park JW; Suh H; Jeong NY; Yoo YH; Kwon TK
Int J Oncol; 2010 Apr; 36(4):1007-13. PubMed ID: 20198347
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
Kim DH; Kim MJ; Sung B; Suh H; Jung JH; Chung HY; Kim ND
Oncol Rep; 2017 Jan; 37(1):281-288. PubMed ID: 27840966
[TBL] [Abstract][Full Text] [Related]
8. The novel resveratrol analogue HS-1793 induces apoptosis via the mitochondrial pathway in murine breast cancer cells.
Kim HJ; Yang KM; Park YS; Choi YJ; Yun JH; Son CH; Suh HS; Jeong MH; Jo WS
Int J Oncol; 2012 Nov; 41(5):1628-34. PubMed ID: 22940714
[TBL] [Abstract][Full Text] [Related]
9. SAHA treatment overcomes the anti-apoptotic effects of Bcl-2 and is associated with the formation of mature PML nuclear bodies in human leukemic U937 cells.
Lee JS; Jeong SH; Soung YH; Kim TH; Choi HJ; Park BS; Kwon TK; Yoo YH
Chem Biol Interact; 2009 Sep; 181(1):61-70. PubMed ID: 19631782
[TBL] [Abstract][Full Text] [Related]
10. HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells.
Kim JA; Kim DH; Hossain MA; Kim MY; Sung B; Yoon JH; Suh H; Jeong TC; Chung HY; Kim ND
Int J Oncol; 2014 Feb; 44(2):473-80. PubMed ID: 24316714
[TBL] [Abstract][Full Text] [Related]
11. Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2.
Gallerne C; Prola A; Lemaire C
Biochim Biophys Acta; 2013 Jun; 1833(6):1356-66. PubMed ID: 23485394
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity.
Park JW; Choi YJ; Suh SI; Baek WK; Suh MH; Jin IN; Min DS; Woo JH; Chang JS; Passaniti A; Lee YH; Kwon TK
Carcinogenesis; 2001 Oct; 22(10):1633-9. PubMed ID: 11577002
[TBL] [Abstract][Full Text] [Related]
13. The targeted inhibition of mitochondrial Hsp90 overcomes the apoptosis resistance conferred by Bcl-2 in Hep3B cells via necroptosis.
Yan C; Oh JS; Yoo SH; Lee JS; Yoon YG; Oh YJ; Jang MS; Lee SY; Yang J; Lee SH; Kim HY; Yoo YH
Toxicol Appl Pharmacol; 2013 Jan; 266(1):9-18. PubMed ID: 23147571
[TBL] [Abstract][Full Text] [Related]
14. The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions.
Choi YJ; Heo K; Park HS; Yang KM; Jeong MH
Int J Oncol; 2016 Oct; 49(4):1479-88. PubMed ID: 27498957
[TBL] [Abstract][Full Text] [Related]
15. HS-1793, a recently developed resveratrol analogue protects rat heart against hypoxia/reoxygenation injury via attenuating mitochondrial damage.
Jeong SH; Hanh TM; Kim HK; Lee SR; Song IS; Noh SJ; Song S; Suh H; Kim N; Rhee BD; Ko KS; Han J
Bioorg Med Chem Lett; 2013 Jul; 23(14):4225-9. PubMed ID: 23735745
[TBL] [Abstract][Full Text] [Related]
16. Chain elongation analog of resveratrol as potent cancer chemoprevention agent.
Kang YF; Qiao HX; Xin LZ; Ge LP
J Physiol Biochem; 2016 Sep; 72(3):445-52. PubMed ID: 27160168
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1.
Niu XF; Liu BQ; Du ZX; Gao YY; Li C; Li N; Guan Y; Wang HQ
BMC Cancer; 2011 Mar; 11():99. PubMed ID: 21418583
[TBL] [Abstract][Full Text] [Related]
18. Lx2-32c, a novel taxane derivative, exerts anti-resistance activity by initiating intrinsic apoptosis pathway in vitro and inhibits the growth of resistant tumor in vivo.
Zhou Q; Li Y; Jin J; Lang L; Zhu Z; Fang W; Chen X
Biol Pharm Bull; 2012; 35(12):2170-9. PubMed ID: 23207769
[TBL] [Abstract][Full Text] [Related]
19. Reversal effect of resveratrol on multidrug resistance in KBv200 cell line.
Quan F; Pan C; Ma Q; Zhang S; Yan L
Biomed Pharmacother; 2008 Nov; 62(9):622-9. PubMed ID: 18804944
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis.
Jazirehi AR; Bonavida B
Mol Cancer Ther; 2004 Jan; 3(1):71-84. PubMed ID: 14749477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
